04:18 PM EDT, 03/17/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Monday it has appointed Thomas Trimarchi as chief financial officer of the company, succeeding Brian Stephenson.

Trimarchi recently assumed the role of principal financial officer and will continue to lead its FP&A and accounting operations, the firm said.

BridgeBio said Stephenson will be leaving the company due to personal reasons but continue to offer his services as a consultant.